Ask what Korea is talking about.

South Korea's government now allows people who have legally purchased weight-loss drugs overseas to bring in up to a three-month supply, Yonhap reports. The Ministry of Food and Drug Safety also issued a safety alert Wednesday to medical professionals and patients over a potential risk of a rare eye condition linked to GLP-1 obesity drugs, including popular treatments, according to the Korea Times. The alert warns of a rare vision-loss risk associated with these drugs.